Drugmaker GlaxoSmithKline will tighten its continuing medical-education funding rules in 2010 with financial support going only to independently designed and executed programs, company officials said in a news release.
GlaxoSmithKline tightening its rules on CME funding
“GSK will not support as many medical education programs, but we will continue funding those with the greatest potential to improve patient health,” said Deirdre Connelly, president of Glaxo North America. The move, she added, is part of the drugmaker's ongoing effort to be more transparent in its business operations and interactions with healthcare providers.
The new policy will restrict eligible CME grant applicants to academic medical centers and their affiliated teaching and patient-care institutions, as well as national professional medical associations. Glaxo said it will no longer fund CME delivered by commercial providers such as medical education and communication companies. The drugmaker will continue posting all approved grants to its company Web site.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.